Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs
Ergosterol is an important constituent of fungal membranes. Azoles inhibit ergosterol biosynthesis, although the cellular basis for their antifungal activity is not understood. We used multiple approaches to demonstrate a critical requirement for ergosterol in vacuolar H+-ATPase function, which is known to be essential for fungal virulence. Ergosterol biosynthesis mutants of S. cerevisiae failed to acidify the vacuole and exhibited multiple vma− phenotypes. Extraction of ergosterol from vacuolar membranes also inactivated V-ATPase without disrupting membrane association of its subdomains. In both S. cerevisiae and the fungal pathogen C. albicans, fluconazole impaired vacuolar acidification, whereas concomitant ergosterol feeding restored V-ATPase function and cell growth. Furthermore, fluconazole exacerbated cytosolic Ca2+ and H+ surges triggered by the antimicrobial agent amiodarone, and impaired Ca2+ sequestration in purified vacuolar vesicles. These findings provide a mechanistic basis for the synergy between azoles and amiodarone observed in vitro. Moreover, we show the clinical potential of this synergy in treatment of systemic fungal infections using a murine model of Candidiasis. In summary, we demonstrate a new regulatory component in fungal V-ATPase function, a novel role for ergosterol in vacuolar ion homeostasis, a plausible cellular mechanism for azole toxicity in fungi, and preliminary in vivo evidence for synergism between two antifungal agents. New insights into the cellular basis of azole toxicity in fungi may broaden therapeutic regimens for patient populations afflicted with systemic fungal infections.
Vyšlo v časopise:
Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000939
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000939
Souhrn
Ergosterol is an important constituent of fungal membranes. Azoles inhibit ergosterol biosynthesis, although the cellular basis for their antifungal activity is not understood. We used multiple approaches to demonstrate a critical requirement for ergosterol in vacuolar H+-ATPase function, which is known to be essential for fungal virulence. Ergosterol biosynthesis mutants of S. cerevisiae failed to acidify the vacuole and exhibited multiple vma− phenotypes. Extraction of ergosterol from vacuolar membranes also inactivated V-ATPase without disrupting membrane association of its subdomains. In both S. cerevisiae and the fungal pathogen C. albicans, fluconazole impaired vacuolar acidification, whereas concomitant ergosterol feeding restored V-ATPase function and cell growth. Furthermore, fluconazole exacerbated cytosolic Ca2+ and H+ surges triggered by the antimicrobial agent amiodarone, and impaired Ca2+ sequestration in purified vacuolar vesicles. These findings provide a mechanistic basis for the synergy between azoles and amiodarone observed in vitro. Moreover, we show the clinical potential of this synergy in treatment of systemic fungal infections using a murine model of Candidiasis. In summary, we demonstrate a new regulatory component in fungal V-ATPase function, a novel role for ergosterol in vacuolar ion homeostasis, a plausible cellular mechanism for azole toxicity in fungi, and preliminary in vivo evidence for synergism between two antifungal agents. New insights into the cellular basis of azole toxicity in fungi may broaden therapeutic regimens for patient populations afflicted with systemic fungal infections.
Zdroje
1. CortiM
PalmeroD
EiguchiK
2009 Respiratory infections in immunocompromised patients. Curr Opin Pulm Med 15 209 217
2. NucciM
AnaissieE
2009 Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation–focus on aspergillosis. Clin Chest Med 30 295 306, vii
3. PappasPG
KauffmanCA
AndesD
BenjaminDKJr
CalandraTF
2009 Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48 503 535
4. HitchcockCA
DickinsonK
BrownSB
EvansEG
AdamsDJ
1990 Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans. Biochem J 266 475 480
5. RyderNS
1985 Effect of allylamine antimycotic agents on fungal sterol biosynthesis measured by sterol side-chain methylation. J Gen Microbiol 131 1595 1602
6. MarcireauC
GuillotonM
KarstF
1990 In vivo effects of fenpropimorph on the yeast Saccharomyces cerevisiae and determination of the molecular basis of the antifungal property. Antimicrob Agents Chemother 34 989 993
7. MaxfieldFR
TabasI
2005 Role of cholesterol and lipid organization in disease. Nature 438 612 621
8. MunroS
2003 Lipid rafts: elusive or illusive? Cell 115 377 388
9. Heese-PeckA
PichlerH
ZanolariB
WatanabeR
DaumG
2002 Multiple functions of sterols in yeast endocytosis. Mol Biol Cell 13 2664 2680
10. JinH
McCafferyJM
GroteE
2008 Ergosterol promotes pheromone signaling and plasma membrane fusion in mating yeast. J Cell Biol 180 813 826
11. SchneiterR
BruggerB
SandhoffR
ZellnigG
LeberA
1999 Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting/remodeling of distinct molecular species en route to the plasma membrane. J Cell Biol 146 741 754
12. KatoM
WicknerW
2001 Ergosterol is required for the Sec18/ATP-dependent priming step of homotypic vacuole fusion. Embo J 20 4035 4040
13. ThorpeGW
FongCS
AlicN
HigginsVJ
DawesIW
2004 Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes. Proc Natl Acad Sci U S A 101 6564 6569
14. UmebayashiK
NakanoA
2003 Ergosterol is required for targeting of tryptophan permease to the yeast plasma membrane. J Cell Biol 161 1117 1131
15. GuptaSS
TonVK
BeaudryV
RulliS
CunninghamK
2003 Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis. J Biol Chem 278 28831 28839
16. CourchesneWE
2002 Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone. J Pharmacol Exp Ther 300 195 199
17. MaresovaL
MuendS
ZhangYQ
SychrovaH
RaoR
2009 Membrane hyperpolarization drives cation influx and fungicidal activity of amiodarone. J Biol Chem 284 2795 2802
18. ZhangYQ
RaoR
2007 Global disruption of cell cycle progression and nutrient response by the antifungal agent amiodarone. J Biol Chem 282 37844 37853
19. MuendS
RaoR
2008 Fungicidal activity of amiodarone is tightly coupled to calcium influx. FEMS Yeast Res 8 425 431
20. ChungJH
LesterRL
DicksonRC
2003 Sphingolipid requirement for generation of a functional v1 component of the vacuolar ATPase. J Biol Chem 278 28872 28881
21. AliR
BrettCL
MukherjeeS
RaoR
2004 Inhibition of sodium/proton exchange by a Rab-GTPase-activating protein regulates endosomal traffic in yeast. J Biol Chem 279 4498 4506
22. BagnatM
KeranenS
ShevchenkoA
SimonsK
2000 Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc Natl Acad Sci U S A 97 3254 3259
23. LeeMC
HamamotoS
SchekmanR
2002 Ceramide biosynthesis is required for the formation of the oligomeric H+-ATPase Pma1p in the yeast endoplasmic reticulum. J Biol Chem 277 22395 22401
24. PerlinDS
HarrisSL
Seto-YoungD
HaberJE
1989 Defective H(+)-ATPase of hygromycin B-resistant pma1 mutants fromSaccharomyces cerevisiae. J Biol Chem 264 21857 21864
25. KanePM
2007 The long physiological reach of the yeast vacuolar H+-ATPase. J Bioenerg Biomembr 39 415 421
26. WatsonPF
RoseME
EllisSW
EnglandH
KellySL
1989 Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals. Biochem Biophys Res Commun 164 1170 1175
27. KellySL
LambDC
KellyDE
ManningNJ
LoefflerJ
1997 Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation. FEBS Lett 400 80 82
28. LiY
PrinzWA
2004 ATP-binding cassette (ABC) transporters mediate nonvesicular, raft-modulated sterol movement from the plasma membrane to the endoplasmic reticulum. J Biol Chem 279 45226 45234
29. WilcoxLJ
BalderesDA
WhartonB
TinkelenbergAH
RaoG
2002 Transcriptional profiling identifies two members of the ATP-binding cassette transporter superfamily required for sterol uptake in yeast. J Biol Chem 277 32466 32472
30. PoltermannS
NguyenM
GuntherJ
WendlandJ
HartlA
2005 The putative vacuolar ATPase subunit Vma7p of Candida albicans is involved in vacuole acidification, hyphal development and virulence. Microbiology 151 1645 1655
31. JiaN
Arthington-SkaggsB
LeeW
PiersonCA
LeesND
2002 Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site. Antimicrob Agents Chemother 46 947 957
32. BrettCL
TukayeDN
MukherjeeS
RaoR
2005 The yeast endosomal Na+K+/H+ exchanger Nhx1 regulates cellular pH to control vesicle trafficking. Mol Biol Cell 16 1396 1405
33. YadavJ
MuendS
ZhangY
RaoR
2007 A phenomics approach in yeast links proton and calcium pump function in the Golgi. Mol Biol Cell 18 1480 1489
34. SerranoR
BernalD
SimonE
ArinoJ
2004 Copper and iron are the limiting factors for growth of the yeast Saccharomyces cerevisiae in an alkaline environment. J Biol Chem 279 19698 19704
35. KawahataM
MasakiK
FujiiT
IefujiH
2006 Yeast genes involved in response to lactic acid and acetic acid: acidic conditions caused by the organic acids in Saccharomyces cerevisiae cultures induce expression of intracellular metal metabolism genes regulated by Aft1p. FEMS Yeast Res 6 924 936
36. PerzovN
Padler-KaravaniV
NelsonH
NelsonN
2002 Characterization of yeast V-ATPase mutants lacking Vph1p or Stv1p and the effect on endocytosis. J Exp Biol 205 1209 1219
37. EricksonT
LiuL
GueyikianA
ZhuX
GibbonsJ
2001 Multiple virulence factors of Cryptococcus neoformans are dependent on VPH1. Mol Microbiol 42 1121 1131
38. KanePM
2000 Regulation of V-ATPases by reversible disassembly. FEBS Lett 469 137 141
39. LafourcadeC
SoboK
Kieffer-JaquinodS
GarinJ
van der GootFG
2008 Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization. PLoS One 3 e2758
40. YoshinakaK
KumanogohH
NakamuraS
MaekawaS
2004 Identification of V-ATPase as a major component in the raft fraction prepared from the synaptic plasma membrane and the synaptic vesicle of rat brain. Neurosci Lett 363 168 172
41. DixonN
PaliT
KeeTP
BallS
HarrisonMA
2008 Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector. Biophys J 94 506 514
42. PaliT
DixonN
KeeTP
MarshD
2004 Incorporation of the V-ATPase inhibitors concanamycin and indole pentadiene in lipid membranes. Spin-label EPR studies. Biochim Biophys Acta 1663 14 18
43. MichelangeliF
EastJM
LeeAG
1990 Structural effects on the interaction of sterols with the (Ca2++Mg2+)-ATPase. Biochim Biophys Acta 1025 99 108
44. CorneliusF
2001 Modulation of Na,K-ATPase and Na-ATPase activity by phospholipids and cholesterol. I. Steady-state kinetics. Biochemistry 40 8842 8851
45. AbeF
UsuiK
HirakiT
2009 Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae. Biochemistry 48 8494 8504
46. LambD
KellyD
KellyS
1999 Molecular aspects of azole antifungal action and resistance. Drug Resist Updat 2 390 402
47. KobayashiD
KondoK
UeharaN
OtokozawaS
TsujiN
2002 Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 46 3113 3117
48. SwamyKM
KimHN
SohJH
KimY
KimSJ
2009 Manipulation of fluorescent and colorimetric changes of fluorescein derivatives and applications for sensing silver ions. Chem Commun (Camb) 1234 1236
49. BenaimG
SandersJM
Garcia-MarchanY
ColinaC
LiraR
2006 Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. J Med Chem 49 892 899
50. GuoQ
SunS
YuJ
LiY
CaoL
2008 Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods. J Med Microbiol 57 457 462
51. AfeltraJ
VitaleRG
MoutonJW
VerweijPE
2004 Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Chemother 48 1335 1343
52. GamarraS
RochaEM
ZhangYQ
ParkS
RaoR
2010 Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans. Antimicrob Agents Chemother
53. BienCM
ChangYC
NesWD
Kwon-ChungKJ
EspenshadePJ
2009 Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs. Mol Microbiol 74 672 690
54. RobertsCJ
RaymondCK
YamashiroCT
StevensTH
1991 Methods for studying the yeast vacuole. Methods Enzymol 194 644 661
55. PerlinDS
BrownCL
HaberJE
1988 Membrane potential defect in hygromycin B-resistant pma1 mutants of Saccharomyces cerevisiae. J Biol Chem 263 18118 18122
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 6
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Requirement of NOX2 and Reactive Oxygen Species for Efficient RIG-I-Mediated Antiviral Response through Regulation of MAVS Expression
- Formation of Complexes at Plasmodesmata for Potyvirus Intercellular Movement Is Mediated by the Viral Protein P3N-PIPO
- Insight into the Mechanisms of Adenovirus Capsid Disassembly from Studies of Defensin Neutralization
- Two Novel Point Mutations in Clinical Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection